来那度胺致急性间质性肾炎。
Lenalidomide-induced acute interstitial nephritis.
机构信息
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA.
出版信息
Oncologist. 2010;15(9):961-4. doi: 10.1634/theoncologist.2010-0070. Epub 2010 Aug 13.
Abstract
The first case of biopsy-proven lenalidomide-induced acute interstitial nephritis is presented.
摘要
现报告首例经活检证实的来那度胺诱导的急性间质性肾炎病例。
相似文献
1
Lenalidomide-induced acute interstitial nephritis.来那度胺致急性间质性肾炎。
Oncologist. 2010;15(9):961-4. doi: 10.1634/theoncologist.2010-0070. Epub 2010 Aug 13.
2
Interstitial pneumonitis associated with the immunomodulatory drugs thalidomide and lenalidomide.与免疫调节药物沙利度胺和来那度胺相关的间质性肺炎。
Int J Hematol. 2012 Feb;95(2):223-4. doi: 10.1007/s12185-011-0997-2. Epub 2011 Dec 27.
3
How to prevent deep vein thrombosis in myeloma patients receiving thalidomide or lenalidomide.如何预防接受沙利度胺或来那度胺治疗的骨髓瘤患者发生深静脉血栓形成。
Leuk Lymphoma. 2007 Dec;48(12):2295-7. doi: 10.1080/10428190701742530.
4
Acute lymphoblastic leukemia developing during maintenance therapy with lenalidomide in a patient with multiple myeloma.一名多发性骨髓瘤患者在来那度胺维持治疗期间发生急性淋巴细胞白血病。
Leuk Lymphoma. 2013 Dec;54(12):2753-5. doi: 10.3109/10428194.2013.786072.
5
Lenalidomide-induced cytokine release syndrome in a patient with multiple myeloma.来那度胺诱发的细胞因子释放综合征在一名多发性骨髓瘤患者中的病例报告
Leuk Lymphoma. 2014 Jul;55(7):1691-3. doi: 10.3109/10428194.2013.853300. Epub 2014 Jan 28.
6
A case of DRESS (drug reaction with eosinophilia and systemic symptoms) with acute interstitial nephritis secondary to lenalidomide.一例因来那度胺继发急性间质性肾炎的药物超敏反应伴嗜酸性粒细胞增多和全身症状（DRESS）病例。
J Oncol Pharm Pract. 2014 Aug;20(4):302-4. doi: 10.1177/1078155213502569. Epub 2013 Sep 2.
7
Spontaneous huge hematoma in the abdominal wall after lenalidomide.来那度胺治疗后腹壁自发性巨大血肿。
Intern Med. 2011;50(8):937. doi: 10.2169/internalmedicine.50.5136. Epub 2011 Apr 15.
8
Cytokine profiles in relapsed multiple myeloma patients undergoing febrile reactions to lenalidomide.接受来那度胺发热反应的复发多发性骨髓瘤患者的细胞因子谱
Int J Hematol. 2011 Dec;94(6):583-4. doi: 10.1007/s12185-011-0973-x. Epub 2011 Nov 30.
9
Severe Renal Allograft Rejection Resulting from Lenalidomide Therapy for Multiple Myeloma: Case Report.来那度胺治疗多发性骨髓瘤导致严重肾移植排斥反应：病例报告
Transplant Proc. 2018 Apr;50(3):873-876. doi: 10.1016/j.transproceed.2018.01.014.
10
Neutrophilic dermatosis complicating lenalidomide therapy.来那度胺治疗并发的嗜中性皮肤病
J Am Acad Dermatol. 2009 Oct;61(4):709-10. doi: 10.1016/j.jaad.2008.12.011. Epub 2009 Jul 3.
引用本文的文献
1
Recurrent Fanconi Syndrome Induced by Lenalidomide: A Case Report.来那度胺诱发的复发性范科尼综合征：一例报告
Cureus. 2024 Aug 4;16(8):e66118. doi: 10.7759/cureus.66118. eCollection 2024 Aug.
2
The renal damage and mechanisms relevant to antitumoral drugs.与抗肿瘤药物相关的肾损伤及其机制。
Front Oncol. 2023 Dec 12;13:1331671. doi: 10.3389/fonc.2023.1331671. eCollection 2023.
3
Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022.第一章：癌症药物治疗患者肾功能评估，选自 2022 年癌症药物治疗期间肾损伤管理临床实践指南。
Int J Clin Oncol. 2023 Oct;28(10):1259-1297. doi: 10.1007/s10147-023-02372-4. Epub 2023 Jun 29.
4
Nephrotoxicity associated with anticancer agents: perspective on onconephrology from nephrologists.与抗癌药物相关的肾毒性：肾脏病学家对肿瘤肾脏病学的看法。
Int J Clin Oncol. 2023 May;28(5):625-636. doi: 10.1007/s10147-023-02307-z. Epub 2023 Mar 5.
5
Kinetics of Renal Function during Induction in Newly Diagnosed Multiple Myeloma: Results of Two Prospective Studies by the German Myeloma Study Group DSMM.新诊断多发性骨髓瘤诱导治疗期间的肾功能动力学：德国骨髓瘤研究组DSMM两项前瞻性研究的结果
Cancers (Basel). 2021 Mar 16;13(6):1322. doi: 10.3390/cancers13061322.
6
Nephrotoxicity in cancer treatment: An overview.癌症治疗中的肾毒性：概述
World J Clin Oncol. 2020 Apr 24;11(4):190-204. doi: 10.5306/wjco.v11.i4.190.
7
Anticancer Drug-Induced Acute Kidney Injury.抗癌药物所致急性肾损伤
Kidney Int Rep. 2017 Feb 16;2(4):504-514. doi: 10.1016/j.ekir.2017.02.008. eCollection 2017 Jul.
本文引用的文献
1
Mechanism of action of lenalidomide in hematological malignancies.来那度胺在血液系统恶性肿瘤中的作用机制。
J Hematol Oncol. 2009 Aug 12;2:36. doi: 10.1186/1756-8722-2-36.
2
The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells.抗癌药物来那度胺和泊马度胺可抑制调节性T细胞的增殖和功能。
Cancer Immunol Immunother. 2009 Jul;58(7):1033-45. doi: 10.1007/s00262-008-0620-4. Epub 2008 Nov 14.
3
Azotemia associated with use of lenalidomide in plasma cell dyscrasias.与浆细胞发育异常中使用来那度胺相关的氮质血症。
Leuk Lymphoma. 2008 Jun;49(6):1108-15. doi: 10.1080/10428190802023707.
4
Immunomodulatory drugs in myelodysplastic syndromes.骨髓增生异常综合征中的免疫调节药物。
Expert Opin Investig Drugs. 2006 Jul;15(7):805-13. doi: 10.1517/13543784.15.7.805.
5
Enhancement of ligand-dependent activation of human natural killer T cells by lenalidomide: therapeutic implications.来那度胺增强人自然杀伤T细胞的配体依赖性激活：治疗意义
Blood. 2006 Jul 15;108(2):618-21. doi: 10.1182/blood-2005-10-4184. Epub 2006 Mar 28.
6
Renal safety and efficacy of i.v. bisphosphonates in patients with skeletal metastases treated for up to 10 Years.静脉注射双膦酸盐类药物对骨转移患者长达10年治疗的肾脏安全性和有效性。
Oncologist. 2005 Nov-Dec;10(10):842-8. doi: 10.1634/theoncologist.10-10-842.
7
Renal failure with the use of zoledronic acid.使用唑来膦酸导致的肾衰竭。
N Engl J Med. 2003 Oct 23;349(17):1676-9; discussion 1676-9. doi: 10.1056/NEJM200310233491721.
8
Toxic acute tubular necrosis following treatment with zoledronate (Zometa).唑来膦酸（择泰）治疗后出现的中毒性急性肾小管坏死。
Kidney Int. 2003 Jul;64(1):281-9. doi: 10.1046/j.1523-1755.2003.00071.x.
9
["Occult" renal insufficiency due to evaluating renal function using only serum creatinine].仅使用血清肌酐评估肾功能导致的“隐匿性”肾功能不全
Nefrologia. 2002;22(2):144-51.
10
Drug-induced acute interstitial nephritis.药物性急性间质性肾炎
Kidney Int. 2001 Aug;60(2):804-17. doi: 10.1046/j.1523-1755.2001.060002804.x.
Zotero 插件